Justin Zelin
Stock Analyst at BTIG
(3.02)
# 2,561
Out of 4,361 analysts
331
Total ratings
35%
Success rate
2.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Justin Zelin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IBRX ImmunityBio | Maintained: Buy | $9 | $7.23 | +24.48% | 6 | Feb 2, 2026 | |
| JANX Janux Therapeutics | Maintained: Buy | $100 | $13.78 | +625.69% | 8 | Jan 22, 2026 | |
| NBP NovaBridge Biosciences | Reiterated: Buy | $9 | $1.71 | +426.32% | 5 | Jan 6, 2026 | |
| SNDX Syndax Pharmaceuticals | Maintained: Buy | $56 | $18.39 | +204.51% | 26 | Jan 2, 2026 | |
| AVBP ArriVent BioPharma | Maintained: Buy | $45 | $29.92 | +50.40% | 2 | Jan 2, 2026 | |
| KURA Kura Oncology | Maintained: Hold | n/a | $8.97 | - | 20 | Dec 9, 2025 | |
| TCRX TScan Therapeutics | Reiterated: Hold | n/a | $0.98 | - | 10 | Dec 9, 2025 | |
| JSPR Jasper Therapeutics | Maintained: Buy | $7 | $0.5513 | +1,169.73% | 14 | Dec 2, 2025 | |
| AAPG Ascentage Pharma Group International | Maintained: Buy | $50 | $18.45 | +171.00% | 2 | Dec 2, 2025 | |
| BCAB BioAtla | Maintained: Buy | $10 | $3.53 | +183.29% | 6 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $3.81 | +424.93% | 20 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $62 | $27.87 | +122.46% | 13 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $125 | $29.29 | +326.77% | 36 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.82 | +339.56% | 2 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $35.52 | +26.69% | 3 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $91 | $36.28 | +150.83% | 38 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $91 | $29.64 | n/a | 13 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.0001 | n/a | 5 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $8.11 | n/a | 21 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $1.90 | n/a | 10 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $6.32 | n/a | 15 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $0.7615 | n/a | 22 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.105 | n/a | 8 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.816 | n/a | 14 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4 | $0.7488 | n/a | 1 | Dec 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.17 | n/a | 2 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $0.0013 | n/a | 3 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 → $3 | $5.69 | n/a | 4 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $293.21 | n/a | 2 | Nov 11, 2020 |
ImmunityBio
Feb 2, 2026
Maintained: Buy
Price Target: $9
Current: $7.23
Upside: +24.48%
Janux Therapeutics
Jan 22, 2026
Maintained: Buy
Price Target: $100
Current: $13.78
Upside: +625.69%
NovaBridge Biosciences
Jan 6, 2026
Reiterated: Buy
Price Target: $9
Current: $1.71
Upside: +426.32%
Syndax Pharmaceuticals
Jan 2, 2026
Maintained: Buy
Price Target: $56
Current: $18.39
Upside: +204.51%
ArriVent BioPharma
Jan 2, 2026
Maintained: Buy
Price Target: $45
Current: $29.92
Upside: +50.40%
Kura Oncology
Dec 9, 2025
Maintained: Hold
Price Target: n/a
Current: $8.97
Upside: -
TScan Therapeutics
Dec 9, 2025
Reiterated: Hold
Price Target: n/a
Current: $0.98
Upside: -
Jasper Therapeutics
Dec 2, 2025
Maintained: Buy
Price Target: $7
Current: $0.5513
Upside: +1,169.73%
Ascentage Pharma Group International
Dec 2, 2025
Maintained: Buy
Price Target: $50
Current: $18.45
Upside: +171.00%
BioAtla
Nov 14, 2025
Maintained: Buy
Price Target: $10
Current: $3.53
Upside: +183.29%
Nov 4, 2025
Reiterated: Buy
Price Target: $20
Current: $3.81
Upside: +424.93%
Nov 4, 2025
Reiterated: Buy
Price Target: $62
Current: $27.87
Upside: +122.46%
Oct 30, 2025
Reiterated: Buy
Price Target: $125
Current: $29.29
Upside: +326.77%
Sep 17, 2025
Reiterated: Buy
Price Target: $8
Current: $1.82
Upside: +339.56%
Aug 14, 2025
Reiterated: Buy
Price Target: $45
Current: $35.52
Upside: +26.69%
Aug 11, 2025
Reiterated: Buy
Price Target: $91
Current: $36.28
Upside: +150.83%
Mar 11, 2025
Reiterated: Buy
Price Target: $91
Current: $29.64
Upside: n/a
Jan 14, 2025
Reiterated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Sep 10, 2024
Maintained: Buy
Price Target: $6
Current: $8.11
Upside: n/a
Sep 3, 2024
Reiterated: Buy
Price Target: $5
Current: $1.90
Upside: n/a
May 13, 2024
Reiterated: Buy
Price Target: $30
Current: $6.32
Upside: n/a
Mar 12, 2024
Maintained: Buy
Price Target: $8
Current: $0.7615
Upside: n/a
May 5, 2023
Rated: Hold
Price Target: n/a
Current: $0.105
Upside: n/a
May 5, 2023
Rated: Hold
Price Target: n/a
Current: $0.816
Upside: n/a
Dec 4, 2020
Initiated Coverage: Buy
Price Target: $4
Current: $0.7488
Upside: n/a
Nov 11, 2020
Reiterated: Buy
Price Target: $4
Current: $1.17
Upside: n/a
Nov 11, 2020
Reiterated: Buy
Price Target: $28
Current: $0.0013
Upside: n/a
Nov 11, 2020
Reiterated: Buy
Price Target: $2 → $3
Current: $5.69
Upside: n/a
Nov 11, 2020
Reiterated: Buy
Price Target: $100
Current: $293.21
Upside: n/a